ARPC2 and breast carcinoma: These observations are consistent with frequent overexpression of AURKA and HMMR in BRCA1-mutant breast cancer cell lines and tumors10,11, and suggest that abnormal earlier localization of ARPC2 at mitotic spindle poles is mediated by overexpression of HMMR that triggers AURKA overactivation.